HOME › DRUGS › ERYTHROMYCIN LACTOBIONATE
ACTIVE SUBSTANCE / INN

ERYTHROMYCIN LACTOBIONATE

Brand name(s): ERYTHROMYCIN LACTOBIONATE, ERYTHROCIN, ERYTHROMYCIN
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA215290
ANDA062563
ACTIVE SUBSTANCE
Erythromycin Lactobionate
REGULATORS
FDA
SPONSORS / MAH
EXELA PHARMA, HOSPIRA, NEXUS
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ERYTHROMYCIN LACTOBIONATEANDA211086EXELA PHARMADiscontinued
ERYTHROMYCIN LACTOBIONATEANDA215290NEXUSPrescription
ERYTHROCINNDA050182HOSPIRADiscontinued
ERYTHROCINANDA062638HOSPIRAPrescription
ERYTHROMYCINANDA062563ELKINS SINNDiscontinued

FULL INTELLIGENCE ON ERYTHROMYCIN LACTOBIONATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →